FDA Orange Book · active-ingredient family
Nelfinavir mesylate
Nelfinavir mesylate is approved in 3 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:VIRACEPT · NDA 021503
3
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · powder, tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| VIRACEPTRLD | AGOURON PHARMS | NDA 021503 | — | Apr 30, 2003 | |
| VIRACEPTRLD | AGOURON PHARMS | NDA 020779 | — | Mar 14, 1997 | |
| VIRACEPT | AGOURON PHARMS | NDA 020778 | — | Mar 14, 1997 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Nelfinavir mesylate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

